Skip to main content

Advertisement

Log in

Early and personalized ambulatory follow-up to tailor furosemide and fluid intake according to congestion in post-discharge heart failure

  • IM - ORIGINAL
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

Abstract

Congestive heart failure (CHF) worsening is a worldwide cause of rehospitalization and mortality, specially during the early period after hospitalization. Fluid accumulation plays a key role in the pathophysiology of both acute heart decompensation and disease progression. The effective use of drugs to maintain restored clinical stabilization in recently discharged patients is a difficult task, and it relies on matching the most appropriately tailored therapy to specific clinical profiles. However, no successful treatment has been shown to reduce post-discharge readmission. We evaluated in a case-control study the effectiveness of an early and personalized congestion-guided ambulatory program on medium-term (6 months) compensation in recently discharged CHF patients. Group A (22 patients) underwent a post-discharge close follow-up consisting of: an early clinic visit within 10 days; a second visit within 10 days after the first; and the other visits at month 1, 2, 3 after discharge. Controls (Group B, 21 patients) underwent a conventional ambulatory follow-up only at month 1, 2, 3 after discharge. The ambulatory approach in both groups was based on the monitoring of signs/symptoms of congestion and body weight, body hydration estimation by using bioelectrical impedance analysis (BIA) and laboratory data. This assessment was finalized to tailor furosemide and daily fluid intake at each visit to eliminate clinical or instrumental evidence of persistent congestion relieving the signs and symptoms. At 6 months, Group A was associated with a better clinical compensation (improved hydration state, lower BNP levels and congestion score), an improved quality of life, and reduced re-hospitalizations. We conclude that in CHF the early and personalized ambulatory follow-up based on congestion-guided treatment is effective to optimize management and maintain clinical stability in the post-discharge period.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. The Task Force on Acute Heart Failure of the European Society of Cardiology (2005) Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. Eur Heart J26:384–416

    Google Scholar 

  2. Cotter G, Metra M, Milo-Cotter O et al (2008) Fluid overload in acute heart failure: re-distribution and other mechanisms beyond fluid accumulation. Eur J Heart Fail 10:165–169

    Article  PubMed  Google Scholar 

  3. Parrinello G, Torres D, Paterna S, Di Pasquale P, Licata G (2008) The pathophysiology of acute heart failure: the key role of fluid accumulation. Am Heart J 156:e19

    Article  PubMed  Google Scholar 

  4. Androne SA, Hryniewicz K, Hudaihed A et al (2004) Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes. Am J Cardiol 93:1254–1259

    Article  PubMed  Google Scholar 

  5. Parrinello G, Torres D, Paterna S, Di Pasquale P, Mezzero M, Licata G (2009) The challenge of the volume status assessment in heart failure. Am Heart J 157:e19–e20

    Article  PubMed  Google Scholar 

  6. Parrinello G, Torres D, Paterna S, Licata G (2009) Is there any novelty on the horizon of heart failure management in internal medicine? The evaluation of body fluid accumulation. Intern Emerg Med 4:269–270

    Article  PubMed  Google Scholar 

  7. Torres D, Parrinello G, Paterna S, Di Pasquale P, Torres A, Trapanese C, Licata G (2009) A new option in measuring bioimpedance in congestive heart failure. Am Heart J 158:e1

    Article  PubMed  Google Scholar 

  8. Paterna S, Di Pasquale P, Parrinello G, Fornaciari E, Di Gaudio F, Fasullo S, Giammanco M, Sarullo FM, Licata G (2005) Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study. J Am Coll Cardiol 45:1997–2003

    Article  PubMed  CAS  Google Scholar 

  9. Piccoli A, Rossi B, Pillon L (1994) A new method for monitoring body fluid variation by bioimpedance analysis: the RXc graph. Kidney Int 46:534–539

    Google Scholar 

  10. Di Lenarda A, Scherillo M, Maggioni AP, Acquarone N, Ambrosio GB, Annicchiarico M, Bellis P, Bellotti P, De Maria R, Lavecchia R, Lucci D, Mathieu G, Opasich C, Porcu M, Tavazzi L, Cafiero M, TEMISTOCLE Investigators (2003) Current presentation and management of heart failure in cardiology and internal medicine hospital units: a tale of two worlds–the TEMISTOCLE study. Am Heart J 146:E12

    Article  PubMed  Google Scholar 

  11. Fonarow GC, ADHERE Scientific Advisory Committee (2003) The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med 4:S21e30

    Google Scholar 

  12. Neuberg GW, Miller AB, O’Connor CM, Belkin RN, Carson PE, Cropp AB, Frid DJ, Nye RG, Pressler ML, Wertheimer JH, Packer M, PRAISE Investigators (2002) Prospective RandomizedAmlodipineSurvival Evaluation. Diuretic resistance predicts mortality in patients with advanced heart failure. Am Heart J 144:31–38

    Article  PubMed  Google Scholar 

  13. Gheorghiade M, Filippatos G, Pang PS, et al. (2008) Changes in clinical, neurohormonal, electrolyte, renal, and hepatic profiles during and after hospitalization for acute decompensated heart failure: analysis from the EVEREST trial (late breaking clinical trial). Paper presented at: European Society of Cardiology; September 2, 2008; Munich, Germany

  14. Lucas C, Johnson W, Hamilton MA, Fonarow GC, Woo MA, Flavell CM, Creaser JA, Stevenson LW (2000) Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J 140:840–847

    Article  PubMed  CAS  Google Scholar 

  15. Valle R, Aspromonte N, Giovinazzo P, Carbonieri E, Chiatto M, Di Tano G, Feola M, Milli M, Fontebasso A, Barro S, Bardellotto S, Milani L (2008) B-type natriuretic peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure. J Card Fail 14:219–224

    Article  PubMed  CAS  Google Scholar 

  16. Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM, HARM Study Group (2008) Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 168:1890–1896

    Article  PubMed  Google Scholar 

  17. Parrinello G, Torres D, Paterna S, Di Pasquale P, Licata G (2010) Wet BNP, fluid and hemodynamic status at discharge in acute heart failure. Int J Cardiol 19(145):335–336

    Article  Google Scholar 

  18. Khoury DS, Naware M, Siou J, Blomqvist A, Mathuria NS, Wang J, Shih HT, Nagueh SF, Panescu D (2009) Ambulatory monitoring of congestive heart failure by multiple bioelectric impedance vectors. J Am Coll Cardiol 53:1075–1081

    Article  PubMed  Google Scholar 

  19. Ritzema J, Melton IC, Richards AM, Crozier IG, Frampton C, Doughty RN, Whiting J, Kar S, Eigler N, Krum H, Abraham WT, Troughton RW (2007) Direct left atrial pressure monitoring in ambulatory heart failure patients: initial experience with a new permanent implantable device. Circulation 116:2952–2959

    Google Scholar 

  20. McDonald K (2010) Monitoring fluid status at the outpatient level: the need for more precision. Congest Heart Fail 16(Suppl 1):S52–S55

    Article  PubMed  Google Scholar 

  21. Paterna S, Parrinello G, Cannizzaro S, Fasullo S, Torres D, Sarullo FM, Di Pasquale P (2009) Medium term effects of different dosage of diuretic, sodium and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure. Am J Cardiol 103:93–102

    Article  PubMed  CAS  Google Scholar 

  22. Parrinello G, Torres D, Paterna S, Di Pasquale P, Licata G (2011) Time to ferry heart failure onto new shores: the need to effectively customize long-term therapy. Am Heart J 161:e13–e14

    Article  PubMed  Google Scholar 

  23. Nagueh SF (2007) Hemodynamically tailored therapy in congestive heart failure: alive and well. J Card Fail 13:626–628

    Article  PubMed  Google Scholar 

  24. Metra M, Gheorghiade M, Bonow RO, Dei Cas L (2010) Post-discharge assessment after a heart failure hospitalization: the next step forward. Circulation 122:1782–1785

    Article  PubMed  Google Scholar 

  25. Piccoli A, Nigrelli S, Caberlotto A, Bottazzo S, Rossi B, Pillon L, Maggiore Q (1995) Bivariate normal values of the bioelectrical impedance vector in adult and elderly populations. Am J Clin Nutr 61:269–270

    Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniele Torres.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parrinello, G., Torres, D., Paterna, S. et al. Early and personalized ambulatory follow-up to tailor furosemide and fluid intake according to congestion in post-discharge heart failure. Intern Emerg Med 8, 221–228 (2013). https://doi.org/10.1007/s11739-011-0602-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-011-0602-y

Keywords

Navigation